Cheng-Han Chen, MD, a board certified interventional cardiologist and medical director of the Structural Heart Program at MemorialCare Saddleback Medical Center in Laguna Hills, CA, who was also not involved in the study, said: This study suggests that patients overall receive a benefit to cardiovascular health with semaglutide early in their treatment course even before losing significant body weight
[19] [20] It represents the closest currently available agent to retatrutide in terms of mechanism
Perhaps most importantly, experts emphasize that medication alone is not enough
Tirzepatide works similarly on the GLP-1 receptor, but also binds to the GIP receptor as well
When searching for the right doctor, ensure theyre board-certified and have training in clinical nutrition, weight management, or a related field